Physician profile
James Morse
NPI 1134135627
$1,344.00
in general payments reported to CMS, 2019-2025
19 companies · $43.52 in 2025
The $43.52 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $933 · 2020: $145 · 2021: $84.74 · 2022: $73.92 · 2023: $33.97 · 2024: $29.70 · 2025: $43.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $266.01 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $195.56 | 2019-2024 | |
| Glaxosmithkline, LLC. | $162.61 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.78 | 2019-2020 | |
| Novo Nordisk INC | $65.19 | 2019 | |
| Sanofi-Aventis U.S. LLC | $64.67 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $64.28 | 2019-2020 | |
| Lilly USA, LLC | $51.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $50.94 | 2019 | |
| Sunovion Pharmaceuticals INC. | $40.68 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $39.24 | 2019 | |
| Ucb, INC. | $35.77 | 2019-2020 | |
| Allergan, INC. | $32.33 | 2019 | |
| Astellas Pharma US INC | $24.84 | 2019 | |
| Jazz Pharmaceuticals INC. | $24.48 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $23.60 | 2019 | |
| Gilead Sciences, INC. | $16.24 | 2019 | |
| Radius Health, INC. | $12.39 | 2019 | |
| Abbvie INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Morse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.